AMERICAN FINANCIAL GROUP AMENDS ONCONETIX STAKE

Ticker: ONCO · Form: SC 13G/A · Filed: Jan 26, 2024 · CIK: 1782107

Complexity: simple

Sentiment: neutral

Topics: beneficial-ownership, institutional-investor, amendment

TL;DR

**AMERICAN FINANCIAL GROUP updated its Onconetix stake, watch for shifts.**

AI Summary

AMERICAN FINANCIAL GROUP INC filed an amended SC 13G/A on January 26, 2024, indicating a change in their beneficial ownership of Onconetix, Inc. common stock as of December 31, 2023. This filing, an amendment to a previous Schedule 13G, signals that AMERICAN FINANCIAL GROUP INC, an insurance company, is adjusting its reported stake in Onconetix, a pharmaceutical preparations company. For investors, this matters because it provides updated transparency on a significant institutional holder's position, which can influence market perception and potentially signal a shift in their investment strategy towards Onconetix.

Why It Matters

This filing updates the public on a major institutional investor's holdings, offering insight into their current conviction in Onconetix, Inc. stock.

Risk Assessment

Risk Level: low — This is a routine amendment to a beneficial ownership report, not indicating immediate high risk.

Analyst Insight

An investor should note this update as part of their due diligence on Onconetix, Inc., but not consider it a primary catalyst for immediate action without further context on the specific change in ownership percentage, which is not detailed in this excerpt.

Key Players & Entities

Forward-Looking Statements

FAQ

What is the purpose of this specific filing, SC 13G/A?

This is an amendment (indicated by the 'A' in SC 13G/A) to a Schedule 13G, which is filed by an investor who beneficially owns more than 5% of a company's stock but does not intend to influence or control the company. The amendment updates previously reported information, in this case, regarding AMERICAN FINANCIAL GROUP INC's ownership in Onconetix, Inc.

Who is the 'Subject Company' in this filing?

The 'Subject Company' is Onconetix, Inc., identified by CIK 0001782107, which operates in the Pharmaceutical Preparations industry (SIC 2834).

Who is the 'Filed By' entity in this document?

The 'Filed By' entity is AMERICAN FINANCIAL GROUP INC, identified by CIK 0001042046, which is categorized under Fire, Marine & Casualty Insurance (SIC 6331).

What was the 'Date of Event Which Requires Filing of This Statement'?

The 'Date of Event Which Requires Filing of This Statement' was December 31, 2023, meaning the reported ownership change or status was effective as of that date.

Has Onconetix, Inc. had any recent name changes according to the filing?

Yes, Onconetix, Inc. was formerly known as Blue Water Biotech, Inc. (name change on 20230424) and prior to that, Blue Water Vaccines Inc. (name change on 20190710).

Filing Stats: 682 words · 3 min read · ~2 pages · Grade level 12.4 · Accepted 2024-01-26 06:01:11

Key Financial Figures

Filing Documents

(a)

Item 1(a) Name of Issuer : Onconetix, Inc., a Delaware corporation (the "Company")

(b)

Item 1(b) Address of Issuer's Principal Executive Office : 201 East Fifth Street, Suite 1900, Cincinnati, Ohio 45202

(a)

Item 2(a) Name of Person Filing : American Financial Group, Inc. ("AFG")

(b)

Item 2(b) Address of Principal Business Office : Great American Insurance Group Tower, 301 East Fourth Street, Cincinnati, Ohio 45202

(c)

Item 2(c) Citizenship : U.S.A. – Ohio

(d)

Item 2(d) Title of Class of Securities : Common stock, $0.00001 par value

(e)

Item 2(e) CUSIP Number : 09610B108 Item 3 If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b), check whether the Person Filing is a : (g) a parent holding company or control person in accordance with 240.13d-1(b)(1)(ii)(G). Item 4 (a) See Item 9 of page 2 (b) See Item 11 of page 2. (c) See Items 5-8 of page 2. Item 5 Item 6 Item 7 Identification and Classification of the Subsidiary which Acquired the Security being Reported on by the Parent Holding Company : Great American Insurance Company (IC-Ohio) Item 8 Identification and Classification of Members of the Group : N/A Item 9 Notice of Dissolution of Group : N/A Item 10 Certification : By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11. 3 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. January 26, 2024 American Financial Group, Inc. By: /s/ Mark A. Weiss Name: Mark A. Weiss Title: Senior Vice President 4

View Full Filing

View this SC 13G/A filing on SEC EDGAR

View on Read The Filing